Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.
J Trop Pediatr. 2013 Oct;59(5):343-9. doi: 10.1093/tropej/fmt029. Epub 2013 Apr 24.
The objective of the present study was to find out the predictors of relapse. One hundred fifty children with a first episode of idiopathic nephrotic syndrome were followed for 12 months after initial treatment. Sixty-one (40.7%) children had no relapse, and 89 (59.3%) had relapses. A significantly higher proportion of children with disease onset between 1 and 3 years were relapsers in comparison with those with disease onset at 4-6 (p < 0.03) and 7-13 (p < 0.001) years. Risk of relapse was 2.99 times higher in this 1-3 year age-group as compared with patients aged >6 years (p = 0.001). Children responding between 1 and 2 weeks after start of treatment had a 0.423 times lesser risk of relapse than those who responded after 4 weeks (p = 0.023). Relapsers had significantly higher incidence of infection at relapse than at other time points (p < 0.001). Onset of disease in younger age and delayed response to prednisolone therapy were found as significant predictors for relapse.
本研究旨在探讨复发的预测因素。对 150 例首次发作的特发性肾病综合征患儿进行了 12 个月的随访,这些患儿在初始治疗后。61 名(40.7%)患儿无复发,89 名(59.3%)患儿复发。与疾病起始于 4-6 岁(p<0.03)和 7-13 岁(p<0.001)的患儿相比,1-3 岁发病的患儿复发的比例明显更高。与年龄>6 岁的患儿相比,1-3 岁年龄组患儿的复发风险高 2.99 倍(p=0.001)。治疗开始后 1-2 周内有反应的患儿复发的风险比治疗后 4 周内有反应的患儿低 0.423 倍(p=0.023)。复发时感染的发生率明显高于其他时间点(p<0.001)。研究发现,发病年龄较小和对泼尼松龙治疗的反应延迟是复发的显著预测因素。